β Blockade after myocardial infarction: systematic review and meta regression analysis
暂无分享,去创建一个
Nick Freemantle | J. Mason | N. Freemantle | J. Cleland | James Mason | P. Young | J. Harrison | John Cleland | Philip Young | Jane Harrison
[1] Igor Sartori,et al. Empirical Evidence of Bias. Dimensions of Methodological Quality Associated with Estimates of Treatment Effects in Controlled Trials , 1996 .
[2] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[3] N Freemantle,et al. The evidence for β blockers in heart failure , 1999, BMJ.
[4] Dwight Lemon,et al. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1 , 1987 .
[5] N. Freemantle,et al. DERIVING TREATMENT RECOMMENDATIONS FROM EVIDENCE WITHIN RANDOMIZED TRIALS The Role and Limitation of Meta-Analysis , 1999, International Journal of Technology Assessment in Health Care.
[6] Walker,et al. Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .
[7] J. Desenclos,et al. Risk factors for human hantavirus infection: Franco-Belgian collaborative case-control study during 1995-6 epidemic , 1999, BMJ.
[8] H. Barron,et al. Beta blockers prevent cardiac death following a myocardial infarction: so why are so many infarct survivors discharged without beta blockers? , 1996, American Journal of Cardiology.
[9] R. Doughty,et al. Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials. , 1997, European heart journal.
[10] J. Carlin. Meta-analysis for 2 x 2 tables: a Bayesian approach. , 1992, Statistics in medicine.
[11] M. Eccles,et al. Use of secondary prophylaxis against myocardial infarction in the north of England. , 1991, BMJ.
[12] P. Heidenreich,et al. Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. , 1997, Journal of the American College of Cardiology.
[13] D J Spiegelhalter,et al. Bayesian approaches to random-effects meta-analysis: a comparative study. , 1995, Statistics in medicine.
[14] H. Sacks,et al. Early or Deferred Zidovudine Therapy in HIV-Infected Patients without an AIDS-Defining Illness , 1995, Annals of Internal Medicine.
[15] R. Peto,et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.
[16] S. Gottlieb,et al. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. , 1998, The New England journal of medicine.
[17] R. J. Hayes,et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.
[18] P Smith,et al. The effect of warfarin on mortality and reinfarction after myocardial infarction. , 1990, The New England journal of medicine.
[19] M. Graffar. [Modern epidemiology]. , 1971, Bruxelles medical.
[20] A. Owen. Intravenous β blockade in acute myocardial infarction , 1998 .
[21] L. Bolognese,et al. RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2 , 1988, The Lancet.
[22] A. Owen. Intravenous β blockade in acute myocardial infarction , 1998 .
[23] Eli Warnock,et al. The effect of diltiazem on mortality and reinfarction after myocardial infarction. , 1989, The New England journal of medicine.
[24] N Breslow,et al. Estimators of the Mantel-Haenszel variance consistent in both sparse data and large-strata limiting models. , 1986, Biometrics.
[25] L. Husten. Latest trials on statins show large benefits for wide range of patients , 1997, The Lancet.
[26] L. Wilhelmsen,et al. Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results. , 1974, Lancet.
[27] Walter R. Gilks,et al. BUGS - Bayesian inference Using Gibbs Sampling Version 0.50 , 1995 .
[28] S G Thompson,et al. A likelihood approach to meta-analysis with random effects. , 1996, Statistics in medicine.
[29] Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. , 1989, The New England journal of medicine.
[30] J. Fleiss,et al. Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer: a critique. , 1991, Journal of clinical epidemiology.
[31] K. Channer,et al. Increasing prescription of drugs for secondary prevention after myocardial infarction , 1995, BMJ.
[32] D. McDevitt. The assessment of beta-adrenoceptor blocking drugs in man. , 1977, British journal of clinical pharmacology.
[33] J. Feely,et al. New Drugs. Beta-blockers and sympathomimetics. , 1983, British medical journal.